Literature DB >> 21518020

Stent failure in the management of malignant extrinsic ureteral obstruction: risk factors.

Yoshihiro Kamiyama1, Shinobu Matsuura, Masanori Kato, Yuko Abe, Shunichi Takyu, Kazuyuki Yoshikawa, Yoichi Arai.   

Abstract

There is still controversy surrounding the indications for performing either a retrograde ureteral stent or percutaneous nephrostomy to manage malignant extrinsic ureteral obstruction (MEUO). We retrospectively analyzed 53 patients who underwent a decompression of MEUO using retrograde ureteral stent. Ureteral stent failure occurred in 18 of 53 patients (34%). Multivariate analysis showed that gastrointestinal cancer as the primary disease, poor preoperative performance status and severe preoperative hydronephrosis were independent predictors of stent failure. Based on the present data, we propose an algorithm for the management of MEUO.
© 2011 The Japanese Urological Association.

Entities:  

Mesh:

Year:  2011        PMID: 21518020     DOI: 10.1111/j.1442-2042.2011.02731.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  14 in total

1.  Predicting the failure of retrograde ureteral stent insertion for managing malignant ureteral obstruction in outpatients.

Authors:  Jin-You Wang; Hai-Liang Zhang; Yao Zhu; Xiao-Jian Qin; B O Dai; Ding-Wei Ye
Journal:  Oncol Lett       Date:  2015-11-24       Impact factor: 2.967

Review 2.  Palliative management of malignant upper urinary tract obstruction.

Authors:  P Sountoulides; I Mykoniatis; N Dimasis
Journal:  Hippokratia       Date:  2014 Oct-Dec       Impact factor: 0.471

3.  Nitinol thin films functionalized with CAR-T cells for the treatment of solid tumours.

Authors:  Michael E Coon; Sirkka B Stephan; Vikas Gupta; Colin P Kealey; Matthias T Stephan
Journal:  Nat Biomed Eng       Date:  2019-12-09       Impact factor: 25.671

4.  Percutaneous antegrade ureteral stent placement: single center experience.

Authors:  Güven Kahriman; Nevzat Özcan; Aytaç Doğan; Hakan İmamoğlu; Abdullah Demirtaş
Journal:  Diagn Interv Radiol       Date:  2019-03       Impact factor: 2.630

5.  Metallic ureteral stents in malignant ureteral obstruction: short-term results and radiological features predicting stent failure in patients with non-urological malignancies.

Authors:  Po-Ming Chow; Jui-Shan Hsu; Shuo-Meng Wang; Hong-Jheng Yu; Yeong-Shiau Pu; Kao-Lang Liu
Journal:  World J Urol       Date:  2013-08-10       Impact factor: 4.226

Review 6.  Malignant ureteric obstruction decompression: how much gain for how much pain? A narrative review.

Authors:  Joanna Prentice; Tarik Amer; Ali Tasleem; Omar Aboumarzouk
Journal:  J R Soc Med       Date:  2018-04       Impact factor: 5.344

7.  Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.

Authors:  Mari Ohtaka; Takashi Kawahara; Daiji Takamoto; Taku Mochizuki; Yusuke Hattori; Jun-Ichi Teranishi; Kazuhide Makiyama; Yasuhide Miyoshi; Yasushi Yumura; Masahiro Yao; Hiroji Uemura
Journal:  BMC Urol       Date:  2018-05-08       Impact factor: 2.264

8.  Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction.

Authors:  Sung Han Kim; Boram Park; Jungnam Joo; Jae Young Joung; Ho Kyung Seo; Jinsoo Chung; Kang Hyun Lee
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

9.  Treatment outcomes of ureteral stenting for malignant extrinsic ureteral obstruction: a comparison between polymeric and metallic stents.

Authors:  Jumpei Asakawa; Taro Iguchi; Satoshi Tamada; Noriko Ninomiya; Minoru Kato; Takeshi Yamasaki; Tatsuya Nakatani
Journal:  Cancer Manag Res       Date:  2018-08-28       Impact factor: 3.989

10.  Cystoscopic extraction technique and external drainage rescue of a failed attempt to traverse a severe transplanted ureteral obstruction.

Authors:  Guodong Zhang; Yang Xu; Peng Jin; Zhiyong Xie; Gang Sun
Journal:  Korean J Urol       Date:  2013-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.